Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$15.03−$0.9700 (−6.06%) on the dayAs of the close; data may be delayed.
ELOX price, last 12 months
Key stats
- Previous close
- $16.00
- Open
- $15.95
- Day range
- $14.04 – $16.36
- 52-week range
- $0.00 – $23.40
- Volume
- 27.6K
- Avg volume (20 days)
- 31K
- Market cap
- $51.6M
Performance
1W−13.9%
1M−18.9%
3M+24.8%
6M+1,366,263.6%
YTD+1,366,263.6%
1Y+95.2%
vs S&P 500, 1Y+78.4 pts
Technicals and fundamentals
About Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $51.6M